Cholinesterase inhibition can manage Alzheimer’s disease (AD) by reducing the catalysis of acetylcholine, which ultimately supports the signals transmission and improves the life quality of AD patients. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.